Advantageous benzofuran compositions for mental disorders or enhancement
Pharmaceutically active benzofuran compositions for the treatment of mental disorders or for mental enhancement, including for entactogenic therapy. The present invention also includes benzofuran compounds, compositions, and methods for generally modulating central nervous system activity and treating central nervous system disorders.
1. An enantiomerically enriched mixture of the S-enantiomer and R-enantiomer of a pair of enantiomers selected from those in a) through h) below, wherein the enantiomerically enriched mixture has between 55% and 90% S-enantiomer:
or a pharmaceutically acceptable salt or a mixed salt thereof.
2. The enantiomerically enriched mixture of claim 1 that has at least 60% S-enantiomer.
3. The enantiomerically enriched mixture of claim 1 that has at least 65% S-enantiomer.
4. The enantiomerically enriched mixture of claim 1 that has at least 70% S-enantiomer.
5. The enantiomerically enriched mixture of claim 1 that has at least 75% S-enantiomer.
6. The enantiomerically enriched mixture of claim 1 that has at least 80% S-enantiomer.
7. The enantiomerically enriched mixture of claim 1 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
8. The enantiomerically enriched mixture of claim 1 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
9. The enantiomerically enriched mixture of claim 1 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
10. The enantiomerically enriched mixture of claim 1 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
11. The enantiomerically enriched mixture of claim 1 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
12. The enantiomerically enriched mixture of claim 1 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
13. The enantiomerically enriched mixture of claim 1 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
14. The enantiomerically enriched mixture of claim 1 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
15. An enantiomerically enriched mixture of the S-enantiomer and R-enantiomer of a pair of enantiomers selected from those in a) through h) below, wherein the enantiomerically enriched mixture has between 55% and 90% R-enantiomer:
or a pharmaceutically acceptable salt or a mixed salt thereof.
16. The enantiomerically enriched mixture of claim 15 that has at least 60% R-enantiomer.
17. The enantiomerically enriched mixture of claim 15 that has at least 65% R-enantiomer.
18. The enantiomerically enriched mixture of claim 15 that has at least 70% R-enantiomer.
19. The enantiomerically enriched mixture of claim 15 that has at least 75% R-enantiomer.
20. The enantiomerically enriched mixture of claim 15 that has at least 80% R-enantiomer.
21. The enantiomerically enriched mixture of claim 15 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
22. The enantiomerically enriched mixture of claim 15 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
23. The enantiomerically enriched mixture of claim 15 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
24. The enantiomerically enriched mixture of claim 15 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
25. The enantiomerically enriched mixture of claim 15 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
26. The enantiomerically enriched mixture of claim 15 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
27. The enantiomerically enriched mixture of claim 15 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.
28. The enantiomerically enriched mixture of claim 15 , wherein the mixture comprises
or a pharmaceutically acceptable salt or a mixed salt thereof.